ZNF383 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.450800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.125200E-01
Normal-vs-Stage2
3.494200E-01
Normal-vs-Stage3
1.310640E-01
Normal-vs-Stage4
4.824800E-01
Stage1-vs-Stage2
6.090400E-01
Stage1-vs-Stage3
1.582610E-01
Stage1-vs-Stage4
4.602200E-01
Stage2-vs-Stage3
3.786600E-01
Stage2-vs-Stage4
2.562000E-01
Stage3-vs-Stage4
8.217700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.472800E-01
Normal-vs-AfricanAmerican
2.477600E-01
Normal-vs-Asian
5.332100E-02
Caucasian-vs-AfricanAmerican
6.868800E-01
Caucasian-vs-Asian
3.613800E-01
AfricanAmerican-vs-Asian
3.887800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.858000E-02
Normal-vs-Female
3.525200E-01
Male-vs-Female
7.652600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.241800E-01
Normal-vs-Age(41-60Yrs)
3.829200E-01
Normal-vs-Age(61-80Yrs)
2.908200E-02
Normal-vs-Age(81-100Yrs)
2.784600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.513200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.307600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.817000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.880000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.031770E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.977410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.627800E-02
Normal-vs-Daily Drinker
2.677200E-01
Normal-vs-Weekly Drinker
4.050400E-02
Normal-vs-Occasional Drinker
3.918800E-01
Normal-vs-Social Drinker
3.664600E-01
Non Drinker-vs-Daily Drinker
7.679000E-01
Non Drinker-vs-Weekly Drinker
7.466400E-01
Non Drinker-vs-Occasional Drinker
1.393410E-01
Non Drinker-vs-Social Drinker
2.858800E-01
Daily Drinker-vs-Weekly Drinker
5.546000E-01
Daily Drinker-vs-Occasional Drinker
7.514000E-02
Daily Drinker-vs-Social Drinker
1.769630E-01
Weekly Drinker-vs-Occasional Drinker
3.058200E-01
Weekly Drinker-vs-Social Drinker
4.988200E-01
Occasional Drinker-vs-Social Drinker
7.599000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.681500E-02
Normal-vs-Grade 2
3.500200E-03
Normal-vs-Grade 3
1.028380E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.385850E-01
Grade 1-vs-Grade 3
3.900000E-01
Grade 1-vs-Grade 4
5.681500E-02
Grade 2-vs-Grade 3
5.726800E-01
Grade 2-vs-Grade 4
3.500200E-03
Grade 3-vs-Grade 4
1.028380E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.374400E-01
Normal-vs-NonDiabetic
3.183800E-01
Diabetic-vs-NonDiabetic
6.920200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.694000E-01
Normal-vs-NoPancreatitis
3.306600E-01
Pancreatitis-vs-NoPancreatitis
2.847800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.280800E-01
Normal-vs-N1
3.544200E-01
N0-vs-N1
5.240600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.604400E-01
Normal-vs-TP53-NonMutant
3.983000E-01
TP53-Mutant-vs-TP53-NonMutant
3.693200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
